Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer.
Phase 3 PATINA trial – summary Population - 518 patients with hormone receptor–positive, HER2-positive metastatic...
Phase 3 PATINA trial – summary Population - 518 patients with hormone receptor–positive, HER2-positive metastatic...
This study presents a comprehensive global analysis of haematological malignancies in individuals aged 0-24 years, using...
This real-world study from the Center for International Blood and Marrow Transplant Research evaluated tisagenlecleucel,...
This dual-center retrospective study evaluated survival outcomes for adolescents and young adults (ages 15-40) with acut...
This retrospective study evaluated the impact of anti-HBV prophylaxis on HBV reactivation in T-cell lymphoma (TCL) patie...
Pirtobrutinib is a novel noncovalent BTK inhibitor designed to overcome resistance caused by BTK mutations, particularly...